Comparison of HBV reactivation between patients with high HBV-DNA and low HBV-DNA loads undergoing PD-1 inhibitor and concurrent antiviral prophylaxis

ConclusionWith concurrent antiviral prophylaxis, HBV-DNA load higher than 500  IU/ml should not be a contraindication for PD-1 inhibitor.
Source: Cancer Immunology, Immunotherapy - Category: Cancer & Oncology Source Type: research